Aldosterone blockade in patients with systolic left ventricular dysfunction

被引：27

作者：

Pitt, B ^{[1
]}

机构：

[1] Univ Michigan, Sch Med, Taubman Ctr 3901, Ann Arbor, MI 48109 USA

来源：

CIRCULATION | 2003年 / 108卷 / 15期

关键词：

D O I：

10.1161/01.CIR.0000086776.15268.22

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1790 / 1794

页数：5

共 27 条

[1]

[Anonymous], 1991, JAMA, V265, P3255

[2]

Berry C, 2001, Heart, V85, pE8, DOI 10.1136/heart.85.4.e8

[3] Complications of inappropriate use of spiroholactone in heart failure: When an old medicine spirals out of new guidelines [J].

Bozkurt, B ;

Agoston, I ;

Knowlton, AA .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (02) :211-214

[4] Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production [J].

Brown, NJ ;

Kim, KS ;

Chen, YQ ;

Blevins, LS ;

Nadeau, JH ;

Meranze, SG ;

Vaughan, DE .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) :336-344

[5] Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction [J].

Cooper, HA ;

Dries, DL ;

Davis, CE ;

Shen, YL ;

Domanski, MJ .

CIRCULATION, 1999, 100 (12) :1311-1315

[6] Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology [J].

Delyani, JA .

KIDNEY INTERNATIONAL, 2000, 57 (04) :1408-1411

[7] Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure [J].

Farquharson, CAJ ;

Struthers, AD .

CIRCULATION, 2000, 101 (06) :594-597

[8] New biology of aldosterone, and experimental studies on the selective aldosterone blocker eplerenone [J].

Funder, JW .

AMERICAN HEART JOURNAL, 2002, 144 (05) :S8-S11

[9] Spironolactone and congestive heart-failure [J].

Georges, B ;

Beguin, C ;

Jadoul, M .

LANCET, 2000, 355 (9212) :1369-1370

[10] Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction [J].

Hayashi, M ;

Tsutamoto, T ;

Wada, A ;

Tsutsui, T ;

Ishii, C ;

Ohno, K ;

Fujii, M ;

Taniguchi, A ;

Hamatani, T ;

Nozato, Y ;

Kataoka, K ;

Morigami, N ;

Ohnishi, M ;

Kinoshita, M ;

Horie, M .

CIRCULATION, 2003, 107 (20) :2559-2565

← 1 2 3 →